Abstract
On the 5th of March 2020, South Africa reported its first cases of COVID-19. This signalled the onset of the first COVID-19 epidemic wave in South Africa. The response by the Government of South Africa to the COVID-19 epidemic in South Africa was the use of non-pharmaceutical interventions (NPIs). In this study, a semi-reactive COVID-19 model, the ARI COVID-19 SEIR model, was used to investigate the impact of NPIs in South Africa to understand their effectiveness in the reduction of COVID-19 transmission in the South African population. This study also investigated the COVID-19 testing, reporting, hospitalised cases and excess deaths in the first COVID-19 epidemic wave in South Africa. The results from this study show that the COVID-19 NPI policies implemented by the Government of South Africa played a significant role in the reduction of COVID-19 active, hospitalised cases and deaths in South Africa’s first COVID-19 epidemic wave.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study falls under the ARI COVID-19 Research Project of which the project is currently not funded. Data used in this study was obtained from public sources. ARI would like to thank the members of the ADDRG and ACMRG for their voluntary commitment to working in the ARI COVID-19 Research Project. We would like to thank Professor Tom Moultrie and Dr Sheetal P. Silal from the University of Cape Town for providing consultation in the early modelling phase of the ARI COVID-19 Research project. We acknowledge the work by the National Institute for Communicable Diseases (NICD), Western Cape Department of Health Provincial Health Data Centre (PHDC) and South African Medical Research Council (SAMRC) in which the ARI COVID-19 Projects draws a lot of its data from.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A. All data sourced from public sources.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data in this manuscript can be requested from the The Afrikan Research Initiative via the email: research{at}afrikanresearchinitiative.com. All data is available and free.
